Ascenta Capital is a specialized biotech venture capital firm dedicated to translating scientific innovation into meaningful medicines for patients. Founded with a mission to support innovative biopharmaceutical companies as they advance from preclinical discovery through clinical development, Ascenta Capital makes concentrated investments ranging from $15-30 million while providing strategic operational support alongside capital.
Focus Areas
Investment Types
Notable Investments
